Archive
All News
Every briefing, headline, and filing we've published, newest first.
The WeekFiercePharma ↗
Insulet and Calm are integrating mental health care into diabetes treatment with a series of mindfulness, medi…
The WeekFierceBiotech ↗
Spero pivots to I&I with $1.1B deal for Innovent antibody, sells slice of Utebzi royalties for $105M
Spero Therapeutics is pivoting to immune and inflammation indications through a license agreement for a CD40L …
The WeekBriefing
Jemperli met its main goal in a phase 2 trial for certain rectal cancers, and GSK now plans to seek U.S. appro…
The WeekSTAT News ↗
A former FDA toxicologist has accused the agency of authorizing Zyn nicotine pouches without fully reviewing t…
The WeekPharmaceutical Technology ↗
Novartis has entered a collaboration with Chai Discovery to advance the use of AI in the identification of the…
The WeekBioPharma Dive ↗
The new study results could make Abbott, which has an agreement with Freenome to market the blood-based test, …
The WeekPharmaVoice ↗
Two of the companies are taking a second-go at FDA approval this summer, while another hopes to cement its lea…
The WeekFiercePharma ↗
The three-part video podcast series features Londyn, 15, and Connor, 20, who live with phenylketonuria, or PKU…
The WeekFierceBiotech ↗
Pharma platform company China Medical System Holdings has tapped up existing partner Insilico for a 1.2 billio…
The WeekBriefing
Apnimed is preparing a potential IPO to finance the commercial rollout of its obstructive sleep apnea therapy,…
The WeekPharmaceutical Technology ↗
The FDA has approved two of MSD's anti-PD-1 therapies, Keytruda and Keytruda Qlex, along with Padcev, for adul…
The WeekSTAT News ↗
In a private meeting, HHS officials met with mental health professionals to work on guidance for stopping SSRI…
The WeekBioPharma Dive ↗
This podcast explores how clinical trial supplies move from early planning to global delivery, ensuring invest…
The WeekFiercePharma ↗
Bayer has addressed its need for a capital infusion under a deal to secure 3 billion euros ($3.4 billion) in e…
The WeekFierceBiotech ↗
KKR, the global investment giant, has launched Allyntra as a new, precision-engineered solutions platform for …
The WeekBriefing
The FDA has expanded the use of the Padcev-Keytruda combination in bladder cancer, intensifying competition fo…
The WeekFiercePharma ↗
Fierce Pharma is launching the weekly Oral GLP-1 Tracker, leveraging analysts' notes and IQVIA data to monitor…
The WeekFierceBiotech ↗
Hansoh Pharmaceutical's pair of much-hyped ADCs continue to justify partner GSK's decision to make them priori…
The WeekBriefing
The FDA reported no new hires under PDUFA VII or BsUFA III for FY26 through June, with FY25 and FY24 hiring go…
The WeekSTAT News ↗
Sean Kaufman's views on vaccines may put him at odds with Sen. Bill Cassidy during next week's confirmation he…
The WeekKFF Health News ↗
A new KFF tracker highlights key federal policy actions during President Trump's second term that concern issu…
The WeekBioPharma Dive ↗
GSK claimed the result was a first for an ADC aimed at the "B7-H3" protein, an increasingly popular target of …
The WeekSTAT News ↗
ARPA-H launches bespoke gene therapy push, Lilly and Novo to promote Bridge program, and more biotech news fro…
The WeekPharmaceutical Technology ↗
Bayer's agreement with Apollo comes a little after Bayer broke its pharma dealmaking fast by acquiring Perfuse…
Page 1
Older →
The Insider - Weekly pharma intelligence
Deals, negotiations, and policy analysis. Delivered when it matters.
No sponsored content. No noise. Unsubscribe anytime.